PuSH - Publication Server of Helmholtz Zentrum München

Cuthbert, G.L.* ; Daujat, S.* ; Snowden, A.W.* ; Erdjument-Bromage, H.* ; Hagiwara, T.* ; Yamada, M.* ; Schneider, R.* ; Gregory, P.D.* ; Tempst, P.* ; Bannister, A.J.* ; Kouzarides, T.*

Histone deimination antagonizes arginine methylation.

Cell 118, 545-553 (2004)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Methylation of arginine residues within histone H3 has been linked to active transcription. This modification appears on the estrogen-regulated pS2 promoter when the CARM1 methyltransferase is recruited during transcriptional activation. Here we describe a process, deimination, that converts histone arginine to citrulline and antagonizes arginine methylation. We show that peptidyl arginine deiminase 4 (PADI4) specifically deiminates, arginine residues R2, R8, R17, and R26 in the H3 tail. Deimination by PADI4 prevents arginine methylation by CARM1. Dimethylation of arginines prevents deimination by PADI4 although monomethylation still allows deimination to take place. In vivo targeting experiments on an endogenous promoter demonstrate that PADI4 can repress hormone receptor-mediated gene induction. Consistent with a repressive role for PADI4, this enzyme is recruited to the pS2 promoter following hormone induction when the gene is transcriptionally downregulated. The recruitment of PADI4 coincides with deimination of the histone H3 N-terminal tail. These results define deimination as a novel mechanism for antagonizing the transcriptional induction mediated by arginine methylation.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.000
648
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2004
HGF-reported in Year 0
ISSN (print) / ISBN 0092-8674
e-ISSN 1097-4172
Journal Cell
Quellenangaben Volume: 118, Issue: 5, Pages: 545-553 Article Number: , Supplement: ,
Publisher Cell Press
Publishing Place Cambridge, Mass.
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502800-001
PubMed ID 15339660
Erfassungsdatum 2004-12-31